Suwan Yap's 5 research works with 93 citations and 722 reads, including: Cardioprotective 3′,4′-dihydroxyflavonol attenuation of JNK and p38 MAPK signalling involves CaMKII inhibition

Yap, Suwan ; Drummer, Olaf H. / Prevalence of new psychoactive substances in Victorian fatally-injured drivers. In: Australian Journal of Forensic Sciences. 2016 ; Vol. 48, No. 2. pp. 230-243.

In acute myocardial ischemia (AMI) the optimal treatment is rapid revascularization by angioplasty or pharmacological thrombolysis. While this is essential to resuscitate the ischemic myocardium, it results in further reperfusion injury and extension of the infarction.

Oct 10, 2008 · Addition of an ionisable succinamic acid side chain confers water solubility, and pharmacological analysis revealed loss of vasorelaxant activity and retention of antioxidant activity. This marks the discovery of the first single-acting water-soluble antioxidant flavonol.

Suwan Yap studies Nitric oxide, Bone Biology, and Medical Physiology.

Dr Suwan Yap (with Prof O Woodman) Dr Helena Qin (with Prof O Woodman) Dr Emma Denehy. Dr Benjamin Cao. Dr Phillip van der Peet. Dr Rohan Williams. Dr Mark Richardson. Dr Zalihe Hakki. Dr Gaetano Speciale. Dr Stephanie Bellmaine (with Prof M Pera) Dr Sayali Shah. Dr Tyson Belz. Dr Satvika Burugupalli. Dr Dylan Smith. Dr Pearl Fernandes. Dr ...

Aug 1, 2016 · Throughout the world, road traffic accidents and their consequences are studied to help develop new prevention and enforcement policies and the presence of alcohol and drugs in drivers has been found to be frequent and the cause of fatal outcomes. The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia.

Drummer, Olaf H.; Yap, Suwan. / The involvement of prescribed drugs in road trauma. In: Forensic Science International. 2016 ; Vol. 265. pp. 17-21.

Jan 10, 2014 · In acute myocardial ischemia (AMI) the optimal treatment is rapid revascularization by angioplasty or pharmacological thrombolysis. While this is essential to resuscitate the ischemic myocardium, it results in further reperfusion injury and extension of the infarction.

3',4'-Dihydroxyflavonol (DiOHF) is a cardioprotective flavonol that can decrease ischaemia/reperfusion injury in the heart. DiOHF exhibits antioxidant and vasorelaxant properties that are thought to underlie its cardioprotective activity.